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Abstract
Background: Calcium (Ca) is an essential nutrient for the human body. Despite lively research, there is
uncertainty about Ca requirements in terms of desirable health outcomes including an upper intake level above
which the potential for harm increases.
Objectives: The aim was to conduct a review to update requirements and desirable or harmful health effects of
Ca on the current scientific evidence.
Methods: We searchedMedline and Swemed from January 2000 to December 2011 and included all systematic
reviews that reported Ca supplementation or usual Ca intake on health outcomes. Meta-analyses, randomized
clinical trials and cohort studies were included in the second search betweenMay 2009 andMarch 2011 and an
additional search covering studies till the end of 2011. This review concentrated on studies reporting
independent effects of Ca, although a few recent trials report sole effects of Ca on health outcomes, most trials
use Ca in combination with vitamin D vs. placebo.
Results: In total, we reviewed 38 studies addressing the effects of Ca on bone, pregnancy-related outcomes,
cancers, cardiovascular outcomes, obesity, and mortality. There was a lot of heterogeneity in the study
protocols, which made it difficult to draw any strong conclusions. According to the literature, high Ca
intake seems to have a small positive effect on bone mineral content (BMC) or bone mineral density
(BMD) in children and postmenopausal women. We did not find any consistent evidence on the effects of
Ca on bone health in premenopausal women or men. Also, the evidence that Ca supplementation reduces
fracture incidence is scarce and inconsistent. Maternal diet may influence the peak bone mass of offspring
but more studies are required. There was no overall effect of Ca intake on cancers. Ca was associated with
a decreased risk of breast cancer and a slightly increased risk of prostate cancer in two of the three studies.
No associations were found with other cancers. We found no consistent association between cardiovascular
outcomes and Ca intake except for blood pressure. A small decrease of 24 mmHg in systolic blood
pressure was found in pregnant and in hypertensive subjects with Ca supplementation. Reviewed studies did
not show consistent evidence relating Ca intake to either mortality or obesity.
Conclusion: Based on this evidence, there is no need to change the Nordic recommendations for Ca intake.
However, due to heterogeneity in the studies it is difficult to interpret the results and provide single
summary statement.
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T
his systematic literature review (SR) is a part of
the NNR5 project with the aim of reviewing and
updating the scientific basis of the 4th edition of
the Nordic Nutrition Recommendations (NNR) issued
in 2004 (Nord 2004:13) (1). The NNR5 project is mainly
focused on a revision of those areas in which new
scientific knowledge has emerged since the 4th edition
with special relevance for the Nordic setting. A number
of SRs will form the basis for establishment of dietary
reference values in the 5th edition of NNR.
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Aims
The overall aim was to review the recent scientific data on
requirements and health effects of calcium (Ca) to update
the current dietary reference values valid in Nordic
countries.
The specific objectives of the review on health effects
on Ca in human nutrition are as follows:
(1) Review the scientific evidence to determine, based
on a set of agreed criteria, dietary reference values
for Ca for different life stages (infants, children,
adolescents, adults, elderly, and during pregnancy
and lactation);
(2) Assess the requirement of Ca for adequate growth,
development, and maintenance of health; and
(3) Assess the health effects of different intakes/
exposures of Ca.
Scientific background
At full-term birth, the human infant accrues about 2630
g of Ca, most of which is present in the skeleton as
calcium hydroxyapatite (Ca10[PO4]6[OH]2), which pro-
vides the rigidity necessary for the skeleton to function
mechanically. When the Ca transfer from the placenta
ceases at birth, the newborn infant is dependent on
dietary Ca. Ca is an important regulator of several body
functions, such as muscle contraction, function of the
nervous system, and blood clotting. Due to its vital
importance, Ca concentration in intracellular and extra-
cellular fluid is tightly regulated. Bone tissue serves
as a reservoir and as a source of Ca for these critical
metabolic needs through the process of bone remodelling.
The most important regulators of Ca metabolism (Fig. 1)
in humans are parathyroid hormone (PTH) and 1,25-
dihydroxyvitamin D (1,25-(OH)2D).
Bone is a dynamic and metabolically active tissue; it is
constantly renewed at an average rate of 810% per year,
and the body’s need for Ca relative to skeletal growth and
remodeling varies by life stage. The major physiological
activities include bone accretion during skeletal growth
and maintenance of bone mass after growth is completed.
Ca balance studies have shown that Ca retention is
significantly higher in adolescents than in adults with the
same Ca intake. Later in adult life, net Ca is lost from the
body when bone formation no longer balances with bone
resorption. There are two different types of bone tissue,
which are formed with the same cells and matrix elements,
but they differ in their structure and function. The
peripheral skeleton constitutes 80% of the skeletal mass,
and is composed primarily of cortical bone. About 70% of
the central skeleton is, in turn, trabecular bone. Trabecular
bone, with its greater surface area, is metabolically more
active and is thus more responsive to changes in mineral
homeostasis, whereas the cortical bone fulfills mainly the
mechanical and protective functions. In adults, bone
modeling occurs less frequently than bone remodeling,
particularly in trabecular bone. While the turnover rate of
23% per year in cortical bone is consistent with main-
tenance of mechanical properties, the turnover rate in
trabecular bone is much higher.
Dietary calcium is classically associated with dairy
products, and food supplies such as milk, yoghurt, and
cheese are rich sources of Ca, providing the majority of
Ca in the general diet in the Scandinavian countries.
In Finland (2) and Sweden (3), milk products provide
more than 60% of the dietary calcium intake and in
Norway (4) approximately 70%. The mean intakes in
adult women in these countries vary from 800 to 1,000
mg/day and in men from 1,000 to 1,200 mg/day.
Research/key questions for calcium
(1) What is the relationship between Ca intake and
different outcomes in different population and age
groups?
(2) What is the relationship between Ca intake and
well-established markers of different functional or
clinical outcomes in different population and age
groups?
(3) What is the effect of supplemental Ca on different
outcomes in different population and age groups?
(4) What is the effect of Ca intake from different sources
on Ca metabolism in different population and age
groups?
(5) Which is the interaction of Ca intake from different
sources with iron intake or iron status on health
outcomes in different population and age groups?
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Fig. 1. Endocrine feedback system that maintains serum
calcium concentrations: involvement of 1,25(OH)2D and
parathyroid hormone (PTH).
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(6) Which is the UL (tolerable upper intake level) for Ca
intake for different health outcomes in different
population and age groups?
Methods
Definitions
This review focuses on publications reporting indepen-
dent effects of Ca, although a few recent trials report
sole Ca effects on health outcomes, most trials use Ca in
combination with vitamin D vs. placebo.
The indicators of exposure were dietary calcium,
fortified foods, and supplementation exposure.
Publication types: Questions 14: SRs, Cochrane
database systematic reviews, meta-analyses; Question 5:
cohort studies (longitudinal or prospective studies), inter-
vention studies; Question 6: for adverse effects: rando-
mized controlled trial s(RCTs). Time frames for search:
January 2000April 2009; May 2009June 2010; and July
2010December 2011.
The following outcome measures were included:
. Pregnancy outcomes and growth
. Bone health
. All fractures
jHip fractures
jVertebral fractures
. BMD/osteoporosis
. Bone mass
. Bone quality
. Muscle strength
. All cancers
. Breast cancer
. Colorectal cancer
. Prostate cancer
. Autoimmune diseases
. Diabetes type II
. Obesity/weight control
. Total mortality
. Cardiovascular disease clinical outcomes
The search terms are defined in Appendix A.
The following life stages were included: infants,
children, adolescents, adults, elderly, and pregnancy and
lactation.
The population groups in the search were primarily
Caucasian.
Search methods and terms
Two expert reference librarians designed and conducted
the electronic search strategy based on the research
questions provided by the three investigators. The follow-
ing electronic databases were searched: Medline and
Swemed. The search was conducted using medical subject
heading terms (MESH; see Appendix A). The search was
done in two batches, the first covering January 2000April
2009 and the second May 2009June 2010 and July 2010
February 2011. A complementary search was done at the
end of January 2012 covering the period between the first
searches until the end of December 2011. The search is
documented in Appendix A. In the first search, the
investigators focused only SRs and in the second SRs
and randomized control trials, published after May 2009,
except the study question 5 where all types of studies were
included due to the less number of hits.
Furthermore, we used snowballing for SRs and RCTs,
which was not in the original search.
Selection of articles/studies, data collection, and analyses
The investigators screened all abstracts individually from
the searches, and later all the three investigators made a
common decision on the full-text articles that had been
required from the librarian. From the batches of full-text
articles, we included those that met the criteria for SRs.
In addition regarding study question 5, RCTs, interven-
tion studies, and cohort studies were included. The full-
text articles were examined individually and the three
investigators made a common decision on which articles
should be included and which to be excluded. Eligible
criteria for full-text articles were SR, matching the
research questions and healthy population (not pa-
tients or medication). In the case of clinical studies and
cohort studies, only studies from Europe, Australia, and
North America were included. We recorded the reason
for rejection of all full-text articles (Fig. 2).
Three authors first independently assessed trial quality
and extracted data including adverse events.
Quality assessment of studies
The results of systematic reviews and meta-analyses
were quality assessed and evaluated using the NNR5-
modified AMSTAR quality assessment tolls and incor-
porated in the evidence tables. Quality assessment of the
RCTs and cohort studies was done according to the NNR
guidelines.
Participants
We focused on populations in Europe andNorth America.
However, if other populations were included in the SRs,
we were usually not able to separate them.
Exposure
Dietary calcium or calcium supplements such as calcium
carbonate, calcium citrate, calcium chloride, or calcium
phosphates.
Study quality
There was a lot of heterogeneity in study subjects,
methods, and protocols, making it difficult to interpret
the results and provide single summary statement. The
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sources and dose of Ca varied widely among the studies,
as well as the methods used to assess the amount con-
sumed. For many risk factors, the quality and strength
or direction of association varies among studies. Study
cohorts were mainly Caucasian participants.
Publication bias
Publication bias cannot be ruled out, since relevant studies
were searched by the electronic databases, such asMedline
and Swemed, unpublished or ongoing studies were not
identified. The search was to the end of December 2011.
Reporting and summarizing the evidence
The evidence is summarized in the evidence tables,
Appendix C, tables 16. The included and excluded studies
are listed in Appendix B.
Effects of Ca exposure on outcome measures
Health outcomes
Characteristics of the included studies for each health
outcome are shown in Evidence Tables 16.
Bone health
The results of bone health are shown in Evidence Table 1.
Calcium accrual and bone health in childhood
Calcium accrual. Since more than 99% of body Ca is
present in the skeleton, an adequate Ca intake during the
growth period may be critical in maximizing BMC. In
their longitudinal study, Vatanparast et al. (5) reported
the average accumulation of Ca (standard deviation,
SD) in adolescent Caucasian boys and girls (918 years).
Boys accrued 198.8 (74.5) g bone mass (BMC) per year,
equivalent to 175.4 (65.7) mg calcium per day with the
maximum accrual of 335.9 g from age 13 to 14. Girls
accrued 138.2 (64.2) g BMC per year, equalling 121.8
(56.6) mg calcium per day with the maximum annual
BMC accrual of 226.0 g from age 12 to 13.
Bone health. We found only one SR (graded A) and
one meta-analysis (graded C) addressing bone health
in children. We did not find any data reporting effects of
Ca supplementation on bone fractures as an outcome in
children.
Abstracts retrieved from electronic,
bibliographic searches: 
First search covering January 2000–April 2009: 2715
Second search covering  May 2009–June 2010 
and July 2010–2011: 790
In all: 3505
Inclusion criteria: SR, RCT, cohort 
Abstracts retrieved from electronic,
bibliographic searches
Complimentary search covering to 
December 2011: 390
Inclusion criteria: SR, RCT, cohort
Titles and abstracts
that appeared 
potentially relevant, 
ordered as full
text papers: 171 
Full papers included: 31 Full papers included: 3
Titles and abstracts
that appeared 
potentially relevant, 
ordered as full
text papers: 5 
Titles and abstract very
unlikely to be relevant : 3334 
Titles and abstract very
unlikely to be relevant : 385 
Papers excluded: 140 
• Not a study question
• Not a SR 
• Old version
• withdrawn
Papers excluded: 2 
• Not a study question
• Not a SR 
Snowballing—
December 2011 (4)
Inclusion: SR, RCT, 
Cohort 
Studies included (38)
Fig. 2. Flow chart of the study selection.
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A systematic review of Winzenberg et al. (6) included
RCTs of Ca supplementation either with Ca supplements
or dietary Ca compared with a placebo, with a treatment
period of at least 3 months. The participants were healthy
children aged 318 years, and bone outcomes were
measured after at least 6 months of follow-up. Nineteen
RCTs (N2,859 participants, out of them 1,367 were
randomized to supplements, 1,426 to placebo) met
inclusion criteria. Ca supplementation doses ranged
from 300 to 1,200 mg/day using calcium citrate, calcium
carbonate, calcium phosphate, calcium lactate gluconate,
calcium phosphate milk extract, or milk minerals as a
source of Ca. None of these studies used dairy foods as a
supplement.
There was no statistically significant effect of Ca
supplementation on BMD] (mg/cm2) at the femoral neck
(10 studies) or lumbar spine (11 studies) standardized
mean differences (SMD; 95% CI) being 0.07 (from 0.05
to 0.19) and 0.08 (from 0.04 to 0.20), respectively.
However, there was a small effect on total body BMC (g)
(9 studies) SMDbeing 0.14 (0.010.27), aswell as onupper
limb density (12 studies) (0.14; 0.040.24). This effect is
comparable to about 1.7% greater increase in supplemen-
ted groups. Only the effect in the upper limb persisted
after supplementation ceased (0.14; 0.010.28). In the
subgroup analyses, treatment effects during supplemen-
tation were greater at all sites in females than males,
though not statistically significantly. Baseline Ca intake,
physical activity, pubertal stage, type of supplementation
(milk extract or other), duration of supplementation, and
exceeding the Ca threshold did not significantly modify
the effect. They concluded that although there was a
small effect of Ca supplementation in the upper limb,
the increase in BMD is unlikely to result in a clinically
significant decrease in fracture risk.
Huncharek et al. (7) did a meta-analysis evaluating
the effects of calcium/dairy supplementation on bone
health using BMC (g) as the primary outcome. Initial
pooling of 12 RCTs (N2,460) yielded a summary mean
difference (95%CI) in BMCbetween the Ca supplemented
and placebo arms of 2.05 g (from 3.26 to 7.36 g). Owing
to the heterogeneity of the pooled data, the cal-
culated summary mean difference in BMC is of dubious
validity. When the papers with low baseline Ca intake were
pooled (three studies), a summary mean difference was
49.9 g (24.076.6 g) in total body BMC. Four RCTs con-
tained data on lumbar spine BMC, but due to substantial
differences across these reports, the authors could not
further characterize the effect of Ca supplementation
at the lumbar spine. They concluded that increased
calcium/dairy intake significantly increases total body
and lumbar spine BMC in children with low baseline
intakes. However, it is improbable to demonstrate sig-
nificant differences between groups when both groups are
receiving physiologically adequate amounts of Ca.
In conclusion, there was a small effect of Ca supple-
mentation in the upper limb BMD and total body BMC.
From a physiological point of view Ca is essential for the
skeleton. Other factors, such as vitamin D, may be crucial
in the assessment of the role of Ca intake. Adequate
vitamin D intake may be a crucial factor when assessing
the role of Ca intake.
Bone health in pregnancy and fetal growth
We did not find any SR regarding Ca intake in
pregnancy, but one RCT (graded C) and one longitudinal
follow-up study (graded C).
In addition to genetic and lifestyle factors, adequate
maternal nutrition during pregnancy may be an important
contributor to fetal growth and bone health. In an RCT,
healthy primiparous women (B20-week gestation) with
Ca intake below 600 mg/day received either a Ca sup-
plement of 1,500 mg/day (N231) or a placebo (N230)
(8). There were no bone mass or density measurements
of either the mother or her offspring. However, in addition
to other biometric measurements, femoral and humeral
diaphysis length of the fetus was measured. No differences
were found in fetal biometric measurements between
the supplemented or placebo groups. Similarly, neonatal
characteristics and anthropometric measurements at
delivery were comparable in both groups. They concluded
that Ca supplementation of 1,500 mg/day in pregnant
women with low Ca intake did not appear to impact on
fetal somatic or skeletal growth.
A longitudinal follow-up of a Tasmanian birth cohort,
mainly of Caucasian origin, was used to describe the
association between maternal dietary intake in the third
trimester of pregnancy and bone mass in their offspring at
the age of 16.Maternal Ca intake was positively associated
with lumbar spine BMD, but no association was found
between femoral neck and total body bone mass. After
including all significant nutrients into the same mul-
tivariate regression model, Ca intake was no more
significant (9).
Bone health in adulthood
Optimally, after puberty and throughout most of adult-
hood, bone formation and resorption are balanced.
During this period, bone mass is consolidated, and Ca
requirements are relatively stable. Peak bone mass, the
maximum amount of bone that can be accumulated, is
reached in early adulthood (10, 11). The ability to attain
peak bone mass is affected by genetic background and by
lifestyle factors, such as physical activity and total Ca
intake. Bone is a dynamic tissue, and a number of clinical
studies suggest that increasing bone mass early in life has
a transient effect, but does not confer protection against
later bone loss and osteoporosis (12). The Ca content of
bone at maturity is approximately 1,200 g in women and
1,400 g in men (13, 14). In men, this level remains
Calcium intake in health maintenance
Citation: Food & Nutrition Research 2013, 57: 21082 - http://dx.doi.org/10.3402/fnr.v57i0.21082 5
(page number not for citation purpose)
relatively constant until the onset of age-related bone loss
later in life, and in women until the onset of menopause.
Caucasian women appear to lose as much as 310% of
their trabecular bone per year during the first few years
after menopause and about 1% of their cortical bone per
year during the first decade after menopause. After this
accelerated bone loss period, the loss again levels off
during the postmenopausal years. Lifetime losses may
reach 3040% of peak bone mass among women and
2030% among men (15).
Bone health in premenopausal women
Data are scarce with respect to bone health (mass and
fractures) in premenopausal women. We did not find any
SR data from this millennium reporting effects of Ca sup-
plementation on premenopausal women’s bone health.
Bone health in postmenopausal women
Postmenopausal women are the most common target
populations for research regarding bone health. We
found one SR (graded C) and two meta-analyses (graded
A and C).
The SR by Waugh et al. (16) evaluated risk factors for
low BMD among 40- to 60-year-old women. They found
an inconsistent evidence of an association between the
current Ca intake and BMD (four studies) and insuffi-
cient evidence of an association between the past Ca
intake and BMD (one study). None of these studies were
intervention studies, and Ca intake was self-reported.
They concluded that evidence of an association between
the current Ca intake and BMD was inconsistent and
insufficient for past Ca intake and BMD.
The meta-analysis of Shea et al. (17) included 15 RCTs
with Ca supplementations (N 1,806, out of them 953
were Ca supplemented). The pooled mean (95% CI)
difference in bone loss between the supplemented and
placebo groups in percentage change from baseline was
1.66% (0.922.39%) for the lumbar spine (nine studies),
1.64% (0.702.57%) for the hip (eight studies), and 1.91%
(0.333.50%) for the distal radius (six studies) favoring
the Ca supplementation. They concluded that Ca supple-
mentation alone had a small positive effect on bone
density.
Chung et al. (18) included in their large review the
Ottawa EPC report (19) and did an update search of RCTs
published after that. The review did not separate Ca trials
fromCa in combination with vitaminD trials. The Ottawa
EPC report concluded that overall, there is good evidence
that combined vitamin D3 and Ca supplementation
resulted in small increases in BMD of the spine, total
body, femoral neck, and total hip. The update search of
Chung et al. (18) did not find evidence to change this
conclusion, although quantitative synthesis was limited
due to variable treatment durations and BMD sites.
Bone health in men
The data evaluating the effect of Ca intake on bone
health in men are scarce. We found one SR (graded C) of
Papaioannou et al. (20). They included 14 studies in their
assessment of BMD and Ca intake in men (5 longitudinal
and 9 cross-sectional studies). Cross-sectional studies
showed inconsistent evidence. Five studies showed a
positive association between Ca intake and BMD of the
lumbar spine and hip, whereas four studies did not find
an independent association between Ca intake and BMD
at these bone sites. Also, the five longitudinal studies
showed inconsistent evidence. In two studies, Ca intake
was associated with bone loss. In particular, men in
the lower quartiles of Ca intake (B1,100 mg/day) had
approximately double the rate of bone loss. On the other
hand, three studies did not predict bone loss.
Men with low Ca intake were underrepresented in
these studies. When the participants were classified into
quartiles by dietary Ca intake, the limit of the lowest
quartile was B1,100 mg/day, which is mainly seen to
be a sufficient Ca intake. The authors concluded that
the existing data were inconsistent and did not show that
Ca intake (dietary or supplements) could predict bone
loss.
Fractures
We found one SR (graded A), three meta-analyses (one
graded A, two graded C), one cohort study (graded C),
and one cross-sectional study (graded C) relating Ca
intake and fractures.
Shea et al. (17) found only five RCTs that measured
fracture rate in a meta-analysis from 2002. The study
found no significant reduction in either vertebral fracture
risk ratio (RR, 95% CI) being 0.77 (0.541.09) or in
non-vertebral fractures, RR 0.86 (0.431.72). They also
concluded that the magnitude of reduction in fracture
risk with Ca supplementation alone remains an open
question.
Tang et al. (21) reported in their meta-analysis
whether Ca or Ca in combination with vitamin D prevents
fractures and bone loss. Twenty-nine studieswere included
in the analyses, out of them 17 reported all types of
fractures as an outcome and 24 reported BMD. In total,
64,897 individuals 50 years or older, of them 92% women,
were included. In 16 trials, participants received Ca-only
supplements. Effect of Ca only on fracture risk reduction
(RR; 95% CI) was 0.90 (0.801.00). The difference in RR
between Ca-only supplementation and Cawith vitamin D
combination was very small (0.90 vs. 0.87) and was not
significant. The treatment effect was greater in partici-
pants whose daily intake was low (less than 700 mg/day).
They concluded that the fracture risk reduction was
greater in the trial in which the compliance rate was
high. In addition, the treatment effect was better with Ca
doses of 1,200 mg/day or more.
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Instead of all types of fractures, Bischoff-Ferrari et al.
(22) assessed in their meta-analysis the relationship of Ca
intake to the risk of non-vertebral and hip fractures.
In the included five RCTs, Ca supplementation varied
between 800 and 1,600 mg/day and was compared with
the placebo. Among 6,740 participants (5,666 primarily
postmenopausal women and 1,074 men), the pooled risk
ratio (RR; 95% CI) for non-vertebral fractures was non-
significant, 0.92 (0.811.05). The pooled risk of four
RCTs with separate results for hip fracture (n6,504, 139
hip fractures) was 1.64 (1.022.64). Pooled results from
seven prospective cohort studies (N170,991 women,
2,954 hip fractures) found no association between Ca
intake and hip fracture risk (RR per 300 mg total Ca per
day1.01; 0.971.05). They concluded that Ca intake
was not significantly associated with hip fracture risk in
women or men based on pooled results from prospective
cohort studies. The pooled results from RCTs showed no
reduction in hip fracture risk with Ca supplementation,
and an increased risk was possible.
The Ottawa EPC report (19) was included in the SR
of Chung et al. (18). The authors concluded that Ca
supplementation in combination with vitamin D (most
studies used D3) is effective in reducing fractures and falls
in institutionalized populations, but there is inconsistent
evidence in reducing falls in postmenopausal women
and older men. The update search of Chung et al. (18)
identified one new RCT of female Navy recruit, aged
1735, which showed that vitamin D (800 IU/day) in
combination with Ca (2,000 mg/day) supplementation
can reduce the risk of stress fractures from military
training compared to placebo.
In a Swedish cohort study, Warensjo¨ et al. (23)
evaluated the association between Ca intake and risk of
fractures (n61,433 women born between 1914 and
1948) and osteoporosis (subcohort of 5,022 women).
The participants were divided into quintiles by Ca intake,
and the third quintile was used as a reference group
(range of mean Ca intake: 882992 mg/day). The HR for
the first event of any fracture was 1.18 (1.121.25) and
for hip fracture 1.29 (1.171.43) in the lowest quintile
(Ca intakeB751 mg/day). The risk for osteoporosis was
also higher the OR being 1.47 (1.092.00). The highest
quintile of Ca intake did not further reduce the risk
of fractures of any type, or of osteoporosis, but was
associated with a higher rate of first-event hip fracture
(HR 1.19; 1.061.32).
In their cross-sectional study, Zhong et al. (24)
evaluated the association of Ca intake and dietary protein
intake with risk of fractures in postmenopausal women
aged 50 years or older. They did not find a relationship
between total Ca intake and risk of fractures. However,
the cross-sectional nature does not permit assessment of
causality, and establishing the effect of Ca supplementa-
tion on fractures would require large, relatively long trials
measuring fracture incidence.
Pregnancy-related outcomes
We found two high-quality and one good quality
systematic reviews on the effects of Ca during pregnancy
(Evidence Table 2). The other included studies, one RCT
and one cohort study, had serious flaws in their study
design. Only the results of at least good quality studies
are reviewed here.
Offspring
Buppasiri et al. (25) reviewed 21 RCTs involving 16,602
pregnant women. They found a significant increase of
approximately 65 g (95% CI 16114 g) in birth weight
in children whose mothers had used Ca supplements
during pregnancy compared to babies of non-users (19
trials, 8,287 women; Evidence Table 2). No significant
differences were, however, found in infant with low birth
weight between the two groups.
In the systematic review by Bergel et al. (26) of two
RCTs and three observational studies, no consistent effect
was found on the blood pressure of infants. However,
in children aged 19 years, higher maternal Ca intake
(dietary or from supplements) was associated with lower
systolic blood pressure (mean: 1.92 mmHg, 95% CI 0.71
3.14 mmHg). No association with diastolic blood pres-
sure was found. This finding was supported by another
systematic review of Hofmeyr et al. (27), which found
that the risk of childhood systolic blood pressure greater
than 95th percentile was reduced (514 children: RR 0.59,
95% CI 0.390.91).
Mother
Hofmeyr et al. (27) reviewed 13 randomized trials
comparing at least 1 g daily of Ca during pregnancy
with a placebo. They found that the risk of high blood
pressure was reduced by 35% (12 trials with 15,730
women, RR0.65, 95% CI 0.530.81), the effect being
greatest in women with low baseline Ca intake. In four
small trials among women at high risk of developing
pre-eclampsia (568 women: RR 0.45, 95% CI 0.240.83),
the risk of pre-eclampsia was reduced by 55%.
The results on preterm birth were inconsistent.
Hofmeyr et al. (27) reported that the average risk of
preterm birth was reduced in the Ca group overall
(11 trials, 15,275 women: RR 0.76; 95% CI 0.600.97).
In a systematic review by Buppasiri et al. (25), there were
no statistically significant differences between women
who received Ca supplementation and those who did not
in terms of reducing preterm births (less than 37-week
gestation) (RR 0.90; 95% CI 0.731.11; 12 studies, 15,615
women; random-effects model) and also in less than
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34-week gestation (RR 1.11; 95% CI 0.841.46; three
trials, 5,145 women).
Lactation
We did not find any SR regarding relationships between
Ca intake and lactation.
Cancer
Nine studies (five SR, one meta-analysis, three cohort
studies) with cancer as an outcome were included
(Evidence Table 3). Of these 9 studies, 2 SRs were ranked
as high quality and three cohorts as good quality studies.
Ca intake did not have a consistent association with
different types of cancers; some of the studies showed
protective effect and in some studies Ca was associated
with an increased risk of some type of cancers.
In the three studies of which one was meta-analysis
(28), one systematic review (18) and one cohort study (29)
having breast cancer as an outcome, Ca intakes were
associated with a lower risk of breast cancer (28) in
premenopausal women only (18) and tended to have an
association in the third study (29).
Ca intake was associated with lower risk of recurrence
of colorectal adenomas in one high-quality SR (30) and in
another SR (31) but not with the risk of colorectal cancer
in SR (30) in the general population.
High Ca intake was associated with slightly increased
risk of prostate cancer in two of the three studies (18,
32, 33). Only one of these studies was ranked high
quality.
No significant associations were found with endome-
trial cancer (34), lung cancer (35), or total cancer (18).
Cardiovascular outcomes
Thirteen studies (seven SRs, three RCTs, three cohort
studies) addressed different types or cardiovascular out-
comes (Evidence Table 4). Three of the SRs were ranked
giving high-quality evidence; one SR, one RCT, and one
cohort were ranked as good quality studies. No consis-
tent evidence of Ca intake with other cardiovascular
outcomes other than systolic blood pressure was found in
these studies.
Ca intake or Ca supplementation was not significantly
associated with increased or reduced risk of aortic valve
calcification, coronary artery calcification (CAC) (36),
increased serum lipids (36, 37), stroke or death (36, 38)
or cardiovascular disease mortality (39), atherosclerosis
vascular disease (40), cardiovascular events (41) or abdom-
inal aortic calcification or coronary aortic calcification
(42). In one study (43), Ca supplementation was asso-
ciated with increased risk of myocardial infarction but
not in the others (40, 41). In the only included study that
had diabetes as an outcome (44), the higher Ca intake
was associated with reduced risk of type 2 diabetes.
The cardiovascular outcomes with Ca intake during
pregnancy are reported in pregnancy-related outcomes.
Ca supplementation lowered systolic blood pressure
with 24 mmHg in hypertensive and in pregnant women
(18, 27, 45) in three high-quality SRs. One RCT found a
small effect on blood pressure in those with below median
Ca intakes (37).
Obesity and control of body weight
Three systematic reviews, of these two high quality (18,
46, 47) and two randomized clinical trials (37, 48) with
body weight and/or obesity as an outcome, were included
in this review (Evidence Table 5). No consistent effect was
found. In only one SR (seven RCTs, 794 subjects) (47),
a mean difference of 0.74 and 0.93 kg body fat
favoring higher Ca intake was found. The studies
reviewed did not show convincing evidence or a favorable
effect of Ca intake on body weight.
Total mortality
Mortality as an outcome was assessed in five studies
(two SRs and three cohort studies), of which one SR
was ranked high quality (Evidence Table 6). No consis-
tent effect was found of Ca intake on death of various
causes. The results varied from increased risk of death of
cardiovascular causes (43), to no effect (18, 43), to about
1025% decreased risk all-cause death (38, 39, 49) with
higher Ca intake.
Upper intake level
We did not find any doseresponse data to evaluate the
safety limits of upper intake level. We included only
clinical outcomes, such as all-cause mortality, cancer, and
cardiovascular events. The results of these outcomes have
been described in previous sections. Briefly, we did not
find that calcium/dairy intake is associated with an
increased risk of mortality. On the contrary, all-cause
mortality was lowest in those with the highest use of
Ca (38, 39, 49). The results with relationship to cancer
showed either no relationship or high Ca intake having a
protective association. Prostate cancer was an exception
with inconsistent results. However, observational studies
suggested an increased risk of prostate cancer among
men with high daily Ca intake of more than 2,000 mg
(32, 33).
Discussion
The aim of this review is to find a scientific base for a
Nordic recommendation for dietary intake of Ca.
We analyzed the literature on the relationships between
Ca intake and different health outcomes. We focused on
Kirsti Uusi-Rasi et al.
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published systematic reviews but included a few RCTs
and cohort studies. Some of the SRs included observa-
tional studies as well as RCTs. The quality of the SRs
varied from A to C, while none of the other type of
studies reached the score of A.
Main findings in relationship to the research questions
Doseresponse assessment including exposure range
The difference in Ca intake between the studies, some
estimating total Ca intake, some concentrating on
supplemented Ca, and some neglecting the supplemental
use assessing only dietary intake, complicates the inter-
pretation of Ca effects. Also, the methodology of
assessing dietary Ca intake varies widely from dietary
records of several days and validated food frequency
questionnaires (FFQs) to enquire the use of milk in
general. Amount of milk and milk products, the richest
and most important Ca source in Nordic countries, is
fairly stable simplifying the estimation of Ca intake,
which is still challenging. Although the participants are
willing to record their diet to the best of their ability,
there may be a discrepancy between actual and reported
Ca intake. The most common method is an FFQ with
varying number of items on the list. If the FFQ is
validated for the study at issue, it mainly works well, but
often the FFQ is done for different purposes, for
different age groups or even for different ethnic groups.
Single 24-h recalls have a problem, because individual
estimates may not represent usual intake.
The use of terminology is not always clear. Some
studies use the term Ca supplementation but also include
the use of vitamin D in combination with Ca supple-
ments. Thus, it is not possible to evaluate the sole
Ca effect. Owing to increasing interest in vitamin D
and health, recent studies focus on the use of Ca in
combination with vitamin D, or the comparison is done
between Ca and CaD without pure placebo groups. Self-
reported uses of Ca supplements may have been asked
with one question without any further enquiry about
name or quantity of the ingredient.
Health outcomes
Bone health
Methodological inadequacies are the biggest limitation in
evaluating factors affecting bone health. Dual energy
X-ray absorptiometry (DXA) provides a reasonable
overall description of bone density, which is a measure
of mineral content of the bone, but overlooks geometric
alterations that can influence bone strength. However, it
is ultimately the whole bone structure, that is, its shape
and size, mean cortical thickness, cortical, and trabecular
density not its mass, mineral content, or areal density
(BMC or BMD) that determines bone mechanical
competence. Although BMD correlates directly with the
change in bone mass, it does not take into account
possible dimensional, material, or structural properties
of bone, and is subject to inherent uncertainty (50, 51).
A consideration of geometric properties emphasizes that
both the amount and location of bone mineral are
important. Age-related loss of bone mass is not necessa-
rily accompanied by a proportionate age-related loss of
bone strength because geometric adaptation may com-
pensate for the loss. Age-related cortical thinning of long
bone shafts, for example, is associated with increased
bone girth, a compensatory change that tends to increase
structural rigidity (52).
Although BMD measured with planar DXA is the
most prevalent outcome in bone research, it does not
represent well all determinants of bone geometric proper-
ties. However, thus far there is limited research evaluating
effects of dietary or supplemental Ca on bone strength or
structure.
In their reviews among children, Winzenberg et al. (6)
included studies with Ca supplements, while Huncharek
et al. (7) reviewed works with dietary Ca and dairy
products. Ca intake affected bone mass positively, and
although the effect was small, Ca intake was crucial in
childhood and youth. Furthermore, the benefit was
especially seen in children with low baseline Ca intake.
It is likely that Ca intake is a necessary but insufficient
condition for the development of a strong skeleton.
However, the results do not support the general use of
Ca supplementation in healthy children. Adequate vita-
min D intake may have an essential factor when assessing
the role of Ca intake. There are also some findings that
low Ca intake is more harmful when associated with low
vitamin D status (53).
Most studies on the effects of Ca intake on adult bone
mass concerned postmenopausal women. We were not
able to find any recent SRs about Ca intake and bone
health in premenopausal women after the review of
Welten et al. from the year 1995, where they analyzed
the relationship between Ca intake and bone mass among
young adults between 18 and 50 years of age (54). They
included 33 studies and only 4 of them were intervention
studies. The cross-sectional studies in women suggested a
positive association between Ca intake and bone mass.
Also, the few intervention studies found a consistent
positive effect of a Ca supplement of about 1,000 mg/day
on bone mass. These studies suggest that Ca intake
should be at least 800 mg/day to optimize bone mass.
Due to high heterogeneity, inconsistent results, lack
of RCTs, and limited number of other kind of studies
(one SR included five longitudinal and nine cross-
sectional studies), it is not possible to make any conclu-
sions in the case of men.
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In postmenopausal women, a positive treatment effect
on BMD was evident in most studies. Ca supplementa-
tion had a relatively small, but possibly meaningful,
effect in reducing bone loss (17). Ca in combination with
vitamin D3 supplementation resulted in small increases in
BMD of the spine, femoral neck, and total hip. Based on
included trials, it was less certain whether vitamin D3
supplementation alone has a significant effect on BMD
(18, 21).
Fractures
The evidence that Ca supplementation reduces fracture
incidence is less and inconsistent. Pooled results from
cohort studies did not find significant associations
between the total Ca intake and hip fracture risk in
women or men (22). Also, a longitudinal follow-up of
a Swedish cohort showed increased risk of fragility
fractures and osteoporosis in women with Ca intake
below 751 mg/day. In that cohort, women with the
highest Ca intake (1,137 mg/day) had increased risk
of first-event hip fracture (23). On the other hand, in the
meta-analysis of Tang et al. (21), the treatment effect was
better with doses at or above 1,200 mg/day than with
lower doses, and in individuals who were elderly, had
low dietary Ca intake (B700 mg/day), or were compliant
with Ca supplementation (80%) (21). However, parti-
cipants were mainly women, and the data are limited for
men. Furthermore, Ca supplementation with vitamin D
may be effective in reducing fractures in institutionalized
populations although the influence remains controversial
in general population (18).
As a general conclusion, Ca is essential for bone
health. Although Ca is only one factor contributing to
bone mass and strength, it is essential for correct bone
development, and especially in individuals with a low
intake, sufficient Ca intake will reduce, but not prevent
bone loss. Increased Ca intake suppresses the number of
bone-remodeling sites and augments premature miner-
alization of immature bone, leading to an apparent
increase in bone density. Net bone accumulation will
be greater as Ca intake increases to the point of genetic
program governing growth. Further increases in Ca
intake will produce no further bone accumulation. This
may be different for different stages of growth (55). It has
also been found in postmenopausal women that the rate
of bone loss is significantly lower in the first year of Ca
supplementation than in the second year, especially at
regions where more than half of the bone content is of
the trabecular type. Furthermore, the long-term (34
years) preservation of bone by Ca supplements has been
found mainly at sites with a predominance of cortical
bone, such as the radius and total body, with an annual
turnover rate of only 23%. This slow rate of cortical
bone turnover implies that a steady state is reached many
years later than in trabecular bone. The long-term effect
of additional Ca on bone density and fracture prevention
is therefore not readily revealed by or extrapolated from
randomized bone density studies (56).
Ca supplementation may transiently increase BMD by
reducing the rate of bone remodeling. Increases in bone
mass appear to occur primarily in cortical bone sites, are
most apparent among populations with low Ca intake,
and do not seem to persist beyond the Ca supplementa-
tion period.
Pregnancy-related outcomes
Offspring. The evidence regarding maternal Ca intake
and offspring’s health is scarce and contradictory. In their
RCT, Abalos et al. (8) did not find any difference in fetal
growth between fetuses of women with or without Ca
supplements. However, a small increase of 65 g in birth
weight was found in SR of Buppasiri et al. (25). This
increase is most likely not clinically important, and due to
high heterogeneity this result must be interpreted with
caution. There was no difference in other pregnancy and
infant outcomes (25).
Some results support an association between maternal
Ca intake during pregnancy and offspring systolic blood
pressure among children (26, 27). The evidence is more
consistent among children older than 1 year (26).
Mother. Ca supplementation is associated with a sig-
nificant protective benefit in the prevention of pre-
eclampsia especially in women with low baseline Ca
intake (18, 27). The average risk of high blood pressure
was also reduced with Ca supplementation compared
with a placebo (18, 27). Since pre-eclampsia is a
dangerous life-threatening disorder, in which hyperten-
sion arises, Ca supplementation may be one factor in
reducing the risk of this serious medical condition. Since
pre-eclampsia is a dangerous life-threatening disorder, in
which hypertension arises, in women with low Ca intake
Ca supplementation may be one factor in reducing the
risk of this serious medical condition.
However, there was no evidence that Ca supplementa-
tion had any effect on maternal weight gain during
pregnancy (25).
Lactation. Profound changes in Ca metabolism and
bone mineral status accompany pregnancy both during
gestation and after delivery and lactation. Accumulating
data suggest that the losses are independent of maternal
Ca intake, and largely reversible in subsequent lactation
and after the end of breast-feeding, possibly in connec-
tion with the return of menses (57, 58). This does not
imply that good nutrition, including the maintenance
of adequate Ca intake, is important during lactation.
However, the accumulating data suggest that breast-
feeding women need not consume excess Ca (59).
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Cancer. In general, no association has been found
between increasing Ca intakes and cancer incidence or
mortality (Chung et al. 2009). However, there are
inconsistent findings considering different cancer types.
In women, there was a trend toward lower breast cancer
risk for those with high Ca intake (18, 29, 60).
The results concerning prostate cancer are inconsis-
tent showing slightly increased association, no associa-
tion or inverse association between Ca intake and risk
of prostate cancer (18, 32, 33). The results of Kristal
et al. do not simplify the interpretation. They report that
dietary Ca intake was positively associated with low-
grade cancer but inversely associated with high-grade
cancer.
The results are not unambiguous in aspects of color-
ectal cancer, either. Although there are some findings
that high Ca intake may contribute, to a moderate degree,
to the prevention of adenoma polyps recurrence espe-
cially in patients with a history of adenomas, no apparent
effect was seen in advanced adenomas or in populations
at lower risk (18, 30, 31). More evidence is needed to
recommend the general use of Ca supplements to prevent
colorectal cancer.
The current evidence for a role of Ca in endometrial
carcinomas is too limited to draw any conclusions (34).
Similarly, more evidence is needed about the relationship
between Ca intake and lung cancer, although increased
total Ca intake reduced lung cancer risk in a subgroup
of current smokers and a beneficial trend was seen in
women (35).
Cardiovascular outcomes
Hypertension and blood pressure. Fairly consistent evi-
dence suggests that Ca supplementation lowered systolic
blood pressure among hypertensive adults, but no sig-
nificant effect has been found on diastolic blood pressure
or in normotensive individuals (18, 37, 45).
More data are needed about influences of age, sex,
Ca dose, background dietary Ca, and supplement versus
dietary source on blood pressure.
No consistent evidence of the relationship between Ca
intake and other cardiovascular outcomes was found (36,
37, 3941, 43). Even a possible increased risk concerning
cardiovascular events is inconclusive.
Cardiovascular events. Recently, concern has arisen of
an increased risk of cardiovascular events associated with
Ca supplementation. Bolland et al. (43) suggested an
upward trend in cardiovascular events in older people
taking Ca. However, there are several limitations. Cardi-
ovascular events were not a primary outcome, the events
may not have been well adjudicated, the studies included
are small and the event frequency is low. Moreover, the
total Ca intake was not reported, and the supplementa-
tion was generally 1,0001,200 mg/day. The events may
therefore be associated with intakes higher than the
supplemented dose, perhaps more than 2,000 mg of
calcium per day. So, it is difficult to conclude that Ca
intakes per se in the range of 1,0001,200 mg/day can be
associated with cardiovascular events (60). There are
also opposing findings with no increase in cardiovascular
events (40, 41), and supplements may even improve some
vascular risk factors, e.g., blood pressure (37, 45).
Diabetes
Although Pittas et al. (44) found an inverse association
between Ca or dairy intake and type 2 diabetes or
metabolic syndrome, they concluded that the evidence is
limited because most observational studies are of low
quality, whereas duration of intervention studies was
short, included few participants, or did post-hoc analyses.
Body weight/obesity
No convincing findings regarding benefits of Ca supple-
mentation on body weight loss or weight maintenance
were found. Ca supplementation did not alter weight or
fat gain (18, 37, 46, 47).
Total mortality
The evidence relating total mortality is inconsistent. There
is some proof about increased death of cardiovascular
events (43), also a protective effect of Ca intake, especially
on all-cause mortality (39, 49, 61), or no effect (18, 43).
There are considerable differences between the works
showing a protective influence, which complicates the
interpretation. Mursu et al. (49) reported the use of Ca
supplements in relationship to total mortality in older
women, whereas Kaluza et al. (39) assessed dietary Ca
intake in middle-aged or older men. The follow-up time of
65 years of vander Pols et al. (38) is considerable. Although
the results suggest a beneficial effect of high dairy
consumption in childhood on total mortality in adult-
hood, environmental and socio-economic circumstances
have changed during the follow-up period, but these
changes are impossible to be considered in the analysis.
A much smaller challenge is the difficulty in separating the
Ca effect from the total diet. One possible interpretation is
that high dairy consumption is one factor in a healthy
balanced diet. Also, it is difficult to compare the results of
Bolland et al. (43) (supplement users, mainly women) and
Chung et al. (18), whose result is based on total Ca intake
in one cohort of adult men and their spouses.
Adverse effects
Ca is mainly thought of to be a safe nutrient to be used
as a supplement, although recently there has been much
of debate in the literature about the possible adverse
effects of high Ca supplementation. Discordant data
provided limited proof of the unfavorable effects of high
calcium/dairy intake. So far, only a few studies on the
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whole have reported adverse intestinal discomfort, such
as constipation and gas, being apparently related to the
Ca supplements (18).
Kidney stone formation is an adverse outcome, most
notably among postmenopausal women. However, the
levels of Ca intake that may cause kidney stones within a
normal population cannot be specified with certainty and
are known to be vary depending on a number of factors,
including baseline renal function, pre-existing disease
conditions, and interactions with drugs (61).
In the past, milk-alkali syndrome was often a side
effect of treating peptic ulcer disease with antacids
containing Ca. It is rarely seen today, because newer,
better medications that do not contain Ca are available
for treating ulcers. A more common scenario today is
when someone takes excess calcium carbonate in an
attempt to prevent osteoporosis. Calcium deposits in the
kidneys and in other tissues can occur in milk-alkali
syndrome. High levels of vitamin D can worsen this
condition. This has been reported in persons who take 2 g
or more of calcium per day. Though the modern manage-
ment of peptic ulcer disease has radically changed over
the past decades, milk-alkali syndrome may still occur,
especially in patients who self-medicate for symptoms of
dyspepsia (62).
Doses
The total Ca intake has not been assessed in most of
the studies. There is a huge variation in daily Ca intake.
Few studies have assessed total Ca intake including
dietary and supplemented Ca. Many studies using
supplements have not asked about dietary Ca intake,
but on the other hand some studies assessing dietary Ca
intake have neglected the possible use of supplements.
Doseresponse studies have not been performed.
Study duration
Study duration varied from a short few weeks’ interven-
tions to follow-ups of several years. Short interventions
may be enough to show changes in blood pressure or
serum lipids, whereas evaluation of Ca intake on bone
density takes at least a few months and cardiovascular
events, cancer or fragility fractures need an exposure of
several years.
Heterogeneity
Owing to heterogeneity in the studies, it is difficult
to interpret the results and provide single summary
statement. The sources and dose of Ca vary widely
among the studies, as well as the methods used to assess
the amount consumed. For many risk factors, the
quality and strength or direction of association varies
among studies. Study cohorts were mainly Caucasian
participants.
Substantial differences exist across the studies in many
important factors. Many of the studies enrolled partici-
pants with sufficient or near-sufficient Ca intake, whereas
in others baseline Ca intake was well below the recom-
mended level, especially in reports from Asian popula-
tions which were included in the SRs. Also, the relatively
large range in supplemental doses may complicate the
comparison. Compliance has mostly not been reported or
taken into account.
Limitations
Most studies tested Ca supplementation, not total Ca
intake, i.e., dietary Ca and supplementation. However,
the effect of Ca intake may differ according to baseline Ca
intake. Evaluation of Ca intake in groups, where mean Ca
intake is above the recommended daily intake may mask
individuals with low habitual intake or Ca deficiency.
In addition, several studies examined Ca with vitamin D
supplementation, or the participants are allowed to use
multivitamins and even other Ca or vitamin D supple-
ments were used simultaneously, which makes it difficult
to interpret the results.
Conclusions
We did not find solid evidence for changing the Nordic
recommendations from 2005. Although calcium/dairy
supplementation had a marginal impact on bone health
in the studies, milk and dairy products has to be
considered to be an optimal source of Ca in the Nordic
setting with important effects on bone health. Regarding
children, the effect of Ca supplementation on the skeleton
remained small, but most studies included children with
adequate Ca intake. It is likely that Ca supplementation
has a much greater impact on bone mass accretion in
children with low baseline Ca intake. Similarly in adults,
the treatment effect seems to be greater in participants
with low daily Ca intake.
It is also difficult to separate the effect of Ca from the
combination of Ca and vitamin D.
In addition to skeletal health, there is evidence that
high Ca intake has a protective influence in reducing
blood pressure and pre-eclampsia. The results suggesting
that high supplementary Ca intake has a harmful effect
on health outcomes, especially on cardiovascular health
or prostate cancer are not solid. However, Ca supple-
mentation does not seem to affect weight loss or weight
maintenance, and regarding relationships between Ca
intake and other cancers, the evidence is inconsistent or
contradictory.
However, if individual dietary Ca intake exceeds the
recommendation (depending on the age group), there
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is no need to recommend Ca supplements for safety
reasons. We recognize that these conclusions, which are
based on the current evidence, might change as addi-
tional data about long-term effects of Ca supplementa-
tion become available.
Implications for research
(1) The adverse effects of increased Ca intake on health
outcomes.
(2) Studies including both dietary and supplemental
Ca.
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